Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy

ClinicalTrials.gov ID: NCT00004978

Public ClinicalTrials.gov record NCT00004978. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 11:26 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-Label, Phase III, International Study of Subcutaneous Recombinant IL-2 in Patients With HIV-1 Infection and CD4+ Cell Counts 300/mm^3 or Greater: Evaluation of Subcutaneous Proleukin in a Randomized International Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to see if it is effective to give HIV positive patients recombinant interleukin-2 (rIL-2) in addition to anti-HIV therapy. Patients will be followed over a minimum of 4 years to study the long-term effects of rIL-2 on their HIV disease progression. Anti-HIV therapy has been very successful in treating HIV positive patients and in keeping viral load (level of HIV in the blood) low. However, anti-HIV drugs cannot completely rid the body of the virus, and the immune system is never completely restored in HIV positive patients. Doctors hope that giving patients recombinant interleukin-2 (rIL-2) in addition to their anti-HIV therapy will help improve their immune systems and keep them healthier over a longer period of time. rIL-2 is a hormone naturally produced by the body during an immune response to a microbial infection.

Study identification

NCT ID
NCT00004978
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
4,150 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2000 (Type not available)
Primary completion
Nov 2008 (Actual)
Completion
Nov 2008 (Actual)
Last update posted
Nov 5, 2021

2000 – 2008

United States locations

U.S. sites
78
U.S. states
16
U.S. cities
36
Facility City State ZIP Site status
VA Greater Los Angeles Healthcare System, Infectious Diseases Section CRS Los Angeles California 90073 —
Dr. M. Estes Med. Practice CRS Mill Valley California 94941-3013 —
Dr. Robert Scott Med. Practice CRS Oakland California 94609 —
East Bay AIDS Ctr. CRS Oakland California 94705 —
Dr. Shawn Hassler Med. Practice CRS San Francisco California 94102 —
Positive Health Program Clinic (San Francisco Gen. Hosp.) CRS San Francisco California 94110-0242 —
Positive Health Practice West/ Dr. Steve Deeks CRS San Francisco California 94110 —
Dr. William Owen Med. Practice CRS San Francisco California 94114-1010 —
Dr. Martin Mass Med. Practice CRS San Francisco California 94114 —
San Francisco VAMC, Infectious Diseases Clinic CRS San Francisco California 94121 —
UCSF PHP, Gen. Internal Medicine Practice CRS San Francisco California 94143 —
Castro-Mission Health Ctr. CRS San Francisco California 94144 —
Dr. Virginia Cafaro Med. Practice CRS San Francisco California — —
Denver Infectious Diseases Consultants CRS Denver Colorado 80204-4507 —
Denver Public Health CRS Denver Colorado — —
Univ. of Colorado Health Science Ctr. CRS Denver Colorado — —
Whitman-Walker Clinic CRS Washington D.C. District of Columbia 20009 —
George Washington Univ. Med. Ctr. Infectious Diseases - Clinical Trials Unit CRS Washington D.C. District of Columbia 20037 —
Walter Reed Army Med. Ctr., Infectious Disease Clinic CRS Washington D.C. District of Columbia 20307 —
Washington DC VAMC, Washington Regional AIDS Program, Infectious Diseases CRS Washington D.C. District of Columbia 20422 —
Dr. Timothy A. Price Med. Practice CRS Washington D.C. District of Columbia — —
Miami VAMC CRS Miami Florida 33125 —
Univ. of Miami, Infectious Diseases Clinical Research Unit CRS Miami Florida 33136 —
ARCA, Central Clinc CRS Atlanta Georgia 30308 —
Emory Univ. Crawford Long Hosp. CRS Atlanta Georgia 30308 —
Atlanta VAMC CRS Decatur Georgia 30033 —
Klein & Slotten Medical Associates CRS Chicago Illinois 60610 —
Jesse Brown VAMC CRS Chicago Illinois 60612 —
Univ. of Illinois Family Ctr. for Infectious Disease CRS Chicago Illinois 60612 —
Lakeshore Infectious Disease Associates CRS Chicago Illinois 60657 —
North Side Family Medicine CRS Chicago Illinois 60657 —
Northwestern Memorial Physicians Group CRS Chicago Illinois 60657 —
Med. Ctr. of Louisiana at New Orleans, HIV Outpatient Clinics CRS New Orleans Louisiana 70112 —
Tulane University Health Sciences Center, Louisiana Community AIDS Research Program(LaCARP) CRS New Orleans Louisiana 70112 —
New Orleans VAMC CRS New Orleans Louisiana 70146 —
NIH Clinical Ctr., NIAID HIV Clinic CRS Bethesda Maryland 20814-9692 —
National Naval Med. Ctr., Infectious Diseases Special Immunology Clinic CRS Bethesda Maryland 208995000 —
Henry Ford Hosp. CRS Detroit Michigan — —
Wayne State Univ. CRS Detroit Michigan — —
St. John Hosp. & Med. Ctr., Infectious Diseases Dept. CRS Grosse Pointe Woods Michigan 48236 —
William Beaumont Hosp., Infectious Disease Research CRS Royal Oak Michigan 48073 —
Abbott Northwestern Hosp., Clinic 42 CRS Minneapolis Minnesota 55404 —
Mayo Clinic INSIGHT CRS Rochester Minnesota 55905 —
Cooper Univ. Hosp. CRS Camden New Jersey 07754 —
ID Care Inc. - Hillsborough CRS Hillsborough New Jersey 08844 —
Jersey Shore Univ. Med. Ctr. CRS Neptune City New Jersey 07754 —
New Jersey Community Research Initiative, Jeffrey Bomser Clinic CRS Newark New Jersey 07103 —
Cathedral Healthcare System, St. Michael's Med. Ctr. CRS Newark New Jersey — —
St. Joseph's Hosp. & Med. Ctr. of New Jersey CRS Paterson New Jersey — —
Raritan Bay Med. Ctr., Perth Amboy Division CRS Perth Amboy New Jersey 08861 —
ID Care - Randolph CRS Randolph Township New Jersey 07869 —
Infectious Disease Specialists of N.J., North Jersey Community Research Initiative CRS Union New Jersey 07083 —
The Early Intervention Program at Kennedy Hosp. CRS Voorhees Township New Jersey 08043 —
St. Vincent Hosp. & Med. Ctr. CRS New York New York 10011 —
Harlem Hospital Ctr./Columbia University CRS (Gordin CTU) New York New York 10037 —
Jacobi Med. Ctr., Ambulatory Care Pavillion CRS The Bronx New York 10461 —
Bronx VAMC CRS The Bronx New York 10468 —
Oregon Health & Sciences Univ. Internal Medicine (L-475) CRS Portland Oregon 97201 —
Multnomah County Health Dept., HIV Health Services Ctr. CRS Portland Oregon 97204 —
The Research & Education Group-Portland CRS Portland Oregon 97209 —
Providence Portland Med. Ctr., Ambulatory Care and Education Ctr. CRS Portland Oregon 97213 —
Kaiser Immune Deficiency Clinic of Portland CRS Portland Oregon 97227 —
Legacy Clinic Emanuel CRS Portland Oregon 97301 —
Salem Hosp. CRS Salem Oregon 97301 —
Kaiser Permanente Lancaster Clinic CRS Salem Oregon 97305 —
Temple Univ. School of Medicine CRS Philadelphia Pennsylvania 19140 —
Michael E. DeBakey VAMC CRS Houston Texas 77030 —
Northwest Clinic CRS Houston Texas 77030 —
Thomas Street Clinic CRS Houston Texas 77030 —
Univ. Clinical Research Ctr., Memorial Hermann Hosp. CRS Houston Texas 77030 —
Legacy Community Health Services, Inc., Montrose Clinic, Inc. Houston Texas — —
South Texas Veterans Health Care System, Immunosuppression Clinic CRS San Antonio Texas 78284 —
Hanover Med. Park (Mechanicsville, VA) CRS Mechanicsville Virginia 23116 —
Naval Med. Ctr. Portsmouth CRS Portsmouth Virginia 23708 —
CrossOver Health Ctr. CRS Richmond Virginia 23224 —
South Richmond Health Care Ctr. CRS Richmond Virginia 23224 —
Hunter Holmes McGuire VAMC CRS Richmond Virginia 23249 —
Virginia Commonwealth Univ. Medical Ctr. CRS Richmond Virginia — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 170 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00004978, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 5, 2021 · Synced Nov 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00004978 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →